Rheological parameters of end-organ damages;Rheologische determinanten von endorganschäden

Internist

Volumn 44, Issue 7, 2003, Pages 853-863

  Leschke, M ^a   Klimek, W ^b   Jung, F ^b  

^a KLINIKUM ESSLINGEN   (Germany)

^b NONE

Author keywords

Fibrinogen; Ischemic heart disease; Microcirculation; Rheology; Viscosity

Indexed keywords

FIBRIC ACID DERIVATIVE; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; STATINE DERIVATIVE; UROKINASE;

ANGINA PECTORIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COR PULMONALE; ERYTHROCYTE AGGREGATION; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN SYNTHESIS; FLOW KINETICS; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEMODILUTION; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LUNG ARTERY PRESSURE; MICROCIRCULATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASMA VISCOSITY; POLYCYTHEMIA; REVIEW;

ANGINA PECTORIS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; HUMANS; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; PERIPHERAL NERVOUS SYSTEM DISEASES; PULMONARY CIRCULATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, SENSORY; URINARY PLASMINOGEN ACTIVATOR;

EID: 0038377997     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-0949-x     Document Type: Review

References (58)

1. Barras JP (1969) Blood rheology-general review. Bibl Haematol 33: 277
2. Blombäck B (1996) Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis. Clin Hemorheol 16: 383-477
3. Borst MM, Leschke M, König U, Worth H (1999) Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: Effects on pulmonary hemodynamics, gas exchange and exercise capacity. Respiration 66: 125-132
4. Campeau L (1976) Grading of angina pectoris. Circulation 54: 522-523
5. Chien S, Dellenback R, Gregersen M (1967) Blood viscosity: Influence of erythrocyte deformation. Science 157: 827-829
6. Davies MJ, Thomas AC, Knapman PA, Hangartner JR (1986) Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73: 418
7. Dintenfass L (1985) Influence of plasma proteins on the in vivo and in vitro rheological properties of blood. Clin Hemorheol 5: 191-206
8. Ehrly AM, Schroeder W (1979) Pathophysiology of chronic arterial occlusive disease I. Microcirclatory maldistribution in sceletal musculature. Herz Kreisl 11: 275-278
9. Ehrly AM (1983) Verbesserungen der nutritiven Durchblutung bei peripheren ischimischen Erkrankungen. VASA (Suppl 11): 1-21
10. Elwood PC, Yarnell JWG, Pickering J, Fehily AM, O'Brien JR (1983) Exercise, fibrinogen and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study. Br Heart J 69: 183-187
11. Ernst E (1993) The role of fibrinogen as a cardiovasular risk factor. Atherosclerosis 100: 1-12
12. Fahraeus R (1928) Die Strömungsverhältnisse und die Verteilung der Blutzellen im Gefäßsystem. Klin Wochenschr 7: 100-106
13. Fahraeus R, Lindquist T (1931) The viscosity of blood in narrow capillaries. Am J Physiol 96: 592-596
14. Fuchs J, Weinberger I, Rotenberg Z, Erdberg A, Davidson E, Joshua H, Agmon J (1984) Plasma viscosity in ischemic heart disease. Am Heart J 108: 435-439
15. Fuster V, Badimon L, Badimon J, Chesebro J (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 326: 242
16. Fuster V, Badimon L, Badimon J, Chesebro J (1992) The pathogenesis of coronary artery disease and the acute coronary syndomes (second of two parts). N Engl J Med 326: 310
17. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Lobo J (1994) Fibrinogen and Factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men. Arterioscler Thromb 14: 54-59
18. Jung F, Roggenkamp HG, Ringelstein EB, Leipnitz G, Schneider R, Kiesewetter, Zeller H (1986) Effect of sex, age, body weight, and smoking on plasma visvosity. Klin Wochenschr 64: 1076-1081
19. Jung F, Koscielny J, Mrowietz C, Wolf S, Kiesewetter H, Wenzel E (1990) Einfluß der Hämodilution auf den systemischen und den Kapillarhämatokrit. Infusionstherapie 17: 268-275
20. Jung F, Pindur G, Kiesewetter H (1992) Plasma viscosity dependence on proteins and lipoproteins: Result of the Aachen-study. Clin Hemorheol 12: 557-571
21. Jung F, Nüttgens HP, Klass R, Kiesewetter H, Wenzel E (1994) Rechnergestützte Analyse der Morphologie kutaner Kapillaren bei der humanen Intravitalmikroskopie. Bildgeb Imaging 61: 277-283
22. Jung F (2000) Role of blood plasma viscosity in microcirculation. Keio J Med 49 (Suppl 3): 36-37
23. Jung F, Mrowietz C, Labarrere C, Schuler S, Park JW (2001) Primary cutaneaus microangiopathy in heart recipients. Microvascular Res 62: 154-163
24. Jung F (2002) Probleme und Möglichkeiten zur Quantifizierung der Fließfähigkelt des Blutes: physikalische und klinische Aspekte. In: Angelkort B, Lawall H (Hrsg) Aktuelles aus der klinischen Hämorheologie und Mikrozirkulation.
25. Kannel WB, Wolf PA, Castelli WP, D'Ágostino RB (1987) Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 258: 1183-1186
26. Kim MC, Kini A, Sharma SK (2002) Refractory angina pectoris. Mechanisms and therapeutic options. J Am Coll Cardiol 39: 923-934
27. Kiesewetter H, Jung F, Kolitschke G et al. (1987) Prävalenz, Risikofaktoren und rheologisches Profil der arteriellen Verschlußbankheit: Ergebnisse der Erstuntersuchung der Aachen-Studie. VASA (Suppl 20): 266-269
28. Landgraf H, Ehrly AM (1981) Wirkungen einer Clofibrat-induzierten Senkung der Fibrinogenkonzentration im Blut bei peripheren arteriellen Durchblutungsstörungen. In: Mahler F, Nachbur B (Hrsg) Zerebrale Ischämie. Huber, Bern,S 277-279
29. Landgraf H (1999) Correlation between plasma viscosity and tissue oxygen tension. Clin Hemorheol Microcirc 20:37-40
30. Leschke M, Blanke H, Stellwaag M, Motz W, Strauer BE (1988) Hyperfibrinogenämie und pathologische Plamaviskosität. Dtsch Med Wochenschr 113: 1175-1181
31. Leschke M, Höffken H, Motz W, Blanke H, Schoebel FC, Strauer BE (1992) Chonisch-intermittierende Urokinasetherapie bei therapierefraktärer Angina pectoris. Dtsch Med Wochenschr 117: 81-87
32. Leschke M, Höffken H, Schmidtsdorff A, Blanke H, Egbring R, Joseph K, Strauer BE (1989) Einfluß von Fenofibrat auf Fibrinogenkonzentration und Blutfiuidität. Dtsch Med Wochenschr 114: 939-44
33. Leschke M, Strauer BE (1990) Die Bedeutung rheologischer Mechanismen in der Atherogenese. Drug Res 40: 356-362
34. Leschke M, Worth H, Strauer BE (1994) Pulmonalkreislauf und kardiale Funktion beim Emphysem. Atemw Lungenkrkh 20:190-198
35. Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, Strauer BE (1996) Longterm-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose response trial. J Am Coll Cardiol 27: 575-584
36. Leschke M, Schoebel FC, Schanwell CM, Peters AJ, Jax TW, Mecklenbeck W, Strauer BE (1997) Chronischintermittierende Urokinasetherapie: anti-ischämische und hämodynamische Effekte. Z Kardiol 86 (Suppl 1): 85-94
37. Lowe G (1992) Blood viscosity, lipoproteins, and cardiovascular risk. Circulation 85: 1992-2239
38. Lowe G, Rumley J, Norrie I et al. (2000) Blood rheology, cardiovascular risk factors and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thromb Haemost 84: 553-558
39. Maresca G, Di Blasio A, Marchioli R, Di Minno G (1998) Measuring plasma fibrinogen to predict stroke and myocardial infarction - an update. Arterioscler Thromb Vasc Biol 19: 1368-1377
40. McGrath RL, Weil JV (1978) Adverse effects of normovolemic polycythemia vera and hypoxia on hemodynamics in the dog. Circ Res 43: 793-798
41. Meade TW, Brozovic M, Chakrabarti RR et al. (1986) Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 11: 533-537
42. Milnor WR (1995) Hemodynamics. Williams & Wilkins, Baltimore
43. Neubaur TER, Peters A, Schöbel FC, Leschke M, Strauer BE (1996) Isovolämische Hämodilution bei koronarer Herzkrankheit - klinische und hämodynamische Auswirkungen. Z Kardiol 85: 1-5
44. O'Connor L, Ballantypne D, Pollock JG, Cairney B, Lawrie TDV (1977) Limb blood flow in treated hyperlipoproteinaemic patients with peripheral vascular disease. Atherosclerosis 27: 325-329
45. Park JW, Mrowietz C, Schuler S, Labarrere C, Jung F (2000) Cutaneaus microcirculation in cardiac allograft recipients with severe hypercholsterolemia before diving and after the first HELLP apheresis. Appl Cardiopulmo Pathophysiol 9:19-25
46. Schmid-Schönbein H (1976) Critical closing pressure or yield shear stress as the cause of disturbed peripheral circulation? Acta Chir Scand 465:10-19
47. Schmid-Schönbein H, Rieger H, Gallasch G, Schachtner H (1977) Pathological red cell aggregation (clump aggregation). Bibl Anat 16: 484-489
48. Schmid-Schönbein H (1981) Myokardiale Mikrozirkulation. Wechselwirkung zwischen Vasomotorik und Fließeigenschaften des Blutes. Dtsch Med Wochenschr 106: 1483
49. Schmid-Schönbein H (2001)Wege des Infarzierens. Neue Erkenntnisse durch die in-vivo Rheoskopie. Internist 42: 1196-1218
50. Schoebel FC, Leschke M, Strauer BE (1995) Therapie-refraktäre Angina pectoris: pathophysiologische Grundlagen und alternative Therapieansätze. Dtsch Med Wochenschr 120: 301-307
51. Schoebel FC, Frazler H, Jessurun GAJ et al. (1997) Refractory angina pectoris in end stage coronary artery disease: Evolving therapeutic concepts. Am Heart J 134: 587-602
52. Schuff-Werner P, Schütz E, Seyde WC, Eisenhauer G, Janning G, Armstrong VW, Seidel D (1989) Improved hemorheology associated with a reduction in plasma-fibrinogen and LDL in patients being treated by-heparin induced extracorporal precipitation. Eur J Clin Invest 19: 30-37
53. Strauer BE, Fatah-Moghadam A, Kment A, Samtleben W, Volger E (1981) Use of plasmapheresis and immunosuppressive therapy in coronary microangiopathies. Bibl Haematol 47: 213-227
54. Stuart J (1984) The acute phase reaction and haematological stress syndrome in vascular disease. Int J Microcirculat 3: 257-262
55. Topol EJ, Serruys PW (1998) Frontiers in interventional cardiology. Circulation 98: 1802-1820
56. Wolf R, Lichtlen PR (1995) Die Beziehungen zwischen Plasmafibrinogen und der Funktion der Kollateralgefäße. Z Kardiol 84: 348
57. Wolf S, Schulte K, Arend O, Glöckner WM, Handt S, Jung F, Reim M (1992) Correlation between retinal microcirculation, plasma viscosity and visual function in patients with macroglobulinemia. Clin Hemorheol 12: 725-731
58. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elswood PC (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell Collaborative Heart Disease Sudies. Circulation 83: 836-844